Biomimetics (Basel, Switzerland) · 2025
Mobile Mental Health Screening in EmotiZen via the Novel Brain-Inspired MCoG-LDPSNet.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bormpotsis Christos, Anagnostouli Maria, Sedky Mohamed, Jelastopulu Eleni, Patel Asma
Аннотация
Anxiety and depression affect millions worldwide, yet stigma and long wait times often delay access to care. Mobile mental health apps can decrease these barriers by offering on-demand screening and support. Nevertheless, many machine and deep learning methods used in such tools perform poorly under severe class imbalance, yielding biased, poorly calibrated predictions. To address this challenge, this study proposes MCoG-LDPSNet, a brain-inspired model that combines dual, orthogonal encoding pathways with a novel Loss-Driven Parametric Swish (LDPS) activation. LDPS implements a neurobiologically motivated adaptive-gain mechanism via a learnable β parameter driven by calibration and confidence-aware loss signals that amplifies minority-class patterns while preserving overall reliability, enabling robust predictions under severe data imbalance. On a benchmark mental health corpus, MCoG-LDPSNet achieved AUROC = 0.9920 and G-mean = 0.9451, outperforming traditional baselines like GLMs, XGBoost, state-of-the-art deep models (CNN-BiLSTM-ATTN), and transformer-based approaches. After transfer learning to social media text, the MCoG-LDPSNet maintained a near-perfect AUROC of 0.9937. Integrated into the EmotiZen App with enhanced app features, MCoG-LDPSNet was associated with substantial symptom reductions (anxiety 28.2%; depression 42.1%). These findings indicate that MCoG-LDPSNet is an accurate, imbalance-aware solution suitable for scalable mobile screening of individuals for anxiety and depression.